[Antimetabolites of orotic acid].
D000818:Animals; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000963:Antimetabolites / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D001372:Aza Compounds / Q000494:pharmacology / Q000627:therapeutic use; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D007778:Lactobacillus / Q000187:drug effects; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009943:Organophosphorus Compounds; D009963:Orotic Acid; D010428:Pentosephosphates; D011742:Pyrimidine Nucleotides / Q000096:biosynthesis; D018139:Simplexvirus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D001372:Aza Compounds; D009943:Organophosphorus Compounds; D010428:Pentosephosphates; D011742:Pyrimidine Nucleotides; D009963:Orotic Acid
Antimetabolity orotovoĭ kisloty.